Ascorbic acid increases the number of dopamine neurons in vitro and in transplants to the 6-OHDA-lesioned rat brain.
The inadequate survival of dopamine neurons following intracerebral transplantation is in part attributed to the generation of reactive oxygen species and subsequent oxidative stress. To address this, we investigated whether the antioxidant ascorbic acid (vitamin C) had any effect on the yields of dopamine neurons derived from E14 rat ventral mesencephalic cells in vitro and in grafts. Following in vitro differentiation in medium containing ascorbic acid at concentrations ranging from 20 to 100 microM, significantly more neurons were immunopositive for the marker of mesencephalic dopamine neurons, tyrosine hydroxylase (TH), when compared to standard differentiation conditions containing no ascorbic acid. Mesencephalic cell suspensions supplemented with 100 microM ascorbic acid were also transplanted into unilateral 6-OHDA-lesioned rats and behavioral rotation was assessed at 2, 4, and 6 weeks posttransplantation. Grafts pretreated with ascorbic acid contained significantly more surviving dopamine neurons compared to nontreated grafts. However, no significant difference in rotation score was observed, with both groups showing a reversal and overcompensation of rotational bias. In addition, no evidence of neurogenesis of nigral dopamine neurons was observed in transplant groups. While the increased number of dopamine neurons observed in our study following ascorbic acid treatment may reflect a selective survival effect, our in vitro results suggest that ascorbic acid may act to increase the number dopamine neurons, both in culture and following transplantation, by stimulating dopaminergic differentiation of neural precursors from the fetal ventral mesencephalon.
Bagga
V
V
Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, Wales, UK.
Dunnett
S B
SB
Fricker-Gates
R A
RA
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D016380:Brain Tissue Transplantation; D002454:Cell Differentiation / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects*; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D016332:Fetal Tissue Transplantation; D006801:Humans; D008474:Medial Forebrain Bundle / Q000473:pathology; D008636:Mesencephalon / Q000378:metabolism; D009474:Neurons / Q000187:drug effects* / Q000502:physiology / Q000637:transplantation*; D018384:Oxidative Stress; D016627:Oxidopamine / Q000633:toxicity; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D000975:Antioxidants; D017382:Reactive Oxygen Species; D016627:Oxidopamine; D014446:Tyrosine 3-Monooxygenase; D001205:Ascorbic Acid; D004298:Dopamine